91Ó°ÊÓ

Thursday 22 January 2026
91Ó°ÊÓ Foundation Trust

FOI_9068

Internal Reference Number: FOI_9068

Date Request Received: 27/11/2025 00:00:00

Date Request Replied To: 14/01/2026 00:00:00

This response was sent via: By Email

Request Summary: Haemophilia Questions

Request Category: Companies

 
Question Number 1:
Haem Questionnaires

Haemophilia A

Q1. In the past 12 months [latest 12 months available], how many patients have been diagnosed with the each of the following conditions in your Trust:

Haemophilia A

Acquired Haemophilia A (AHA)

Congenital Haemophilia A with inhibitors CHAwI)
 
Answer To Question 1:
16 patients
 
Question Number 2:
. In the last twelve months[latest 12 months available], how many pts with Haemophilia A, have been treated with each of the following products in your Trust:

Factor Eight Inhibitor Bypass Activity (FEIBA)

Hemlibra (standalone)

Hemlibra in combination with NovoSeven RT

Hemlibra in combination with Cevenfacta

NovoSeven RT

Obizur

Cevenfacta
 
Answer To Question 2:
0 patients
 
Question Number 3:
In the last twelve months[latest 12 months available], how many patients with Acquired Haemophilia A, have been treated with each of the following products in your Trust:


Factor Eight Inhibitor Bypass Activity (FEIBA)

NovoSeven RT

Obizur

Cevenfacta
 
Answer To Question 3:
0 patients
 
Question Number 4:
In the last twelve months[latest 12 months available], how many pts with Congenital Haemophilia A with Inhibitors have been treated with each of the following products in your Trust?

Factor Eight Inhibitor Bypass Activity (FEIBA)

Hemlibra (standalone)

Hemlibra in combination with NovoSeven RT

Hemlibra in combination with Cevenfacta

Hemlibra in combination with FEIBA

Helimbra in combination with Factor VIII

NovoSeven RT

Obizur

Cevenfacta
 
Answer To Question 4:
0 patients
 
Question Number 5:
Prothrombin Complex Concentrate (PCC)

What is the total Prothrombin Complex Concentrate usage in International Units (IUs) for your Trust over the last 12 months [latest 12 months available] for each of the products below in your Trust?

Prothromplex

Beriplex

Octaplex
 
Answer To Question 5:
Octaplex – 500IU – Total from Jan 25 to Sept 25 = 12500IU
Octaplex – 1000IU – Total from Jan 25 to Sept 25 = 48000IU
 
Question Number 6:
Can you share the Prothrombin Complex Concentrate usage in International Units for your Trust in the last 12 months [latest 12 months available] within each of the following departments, and which PCC is used?

Prothromplex

Beriplex

Octaplex


Departments
Cardio-speciality

General Medicine

General surgery

Haematology

Emergency care

Any other
 
Answer To Question 6:

Octaplex – 500IU – Total from Jan 25 to Sept 25 = 12500IU
Octaplex – 1000IU – Total from Jan 25 to Sept 25 = 48000IU




Departments

Cardio-speciality: N/A



General Medicine

Octaplex – 500IU – Total = 1000IU
Octaplex – 1000IU – Total = 14000IU




General surgery

Octaplex – 500IU – Total = 1500IU
Octaplex – 1000IU – Total = 5000IU


Haematology

Octaplex – 500IU – Total = IU
Octaplex – 1000IU – Total = 4000IU


Emergency care

Octaplex – 500IU – Total = 8000IU
Octaplex – 1000IU – Total = 20000IU




Any other

Octaplex – 500IU – Total = 6000IU
Octaplex – 1000IU – Total = 15000IU
 
To return to the list of all the FOI requests please click here

Our staff at 91Ó°ÊÓ District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

91Ó°ÊÓ NHS Foundation Trust, 91Ó°ÊÓ District Hospital, Odstock Road, 91Ó°ÊÓ, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2026 91Ó°ÊÓ NHS Foundation Trust
Trust Values